English High Court grants Arrow declaration in Fujifilm v AbbVie

06-03-2017

English High Court grants Arrow declaration in Fujifilm v AbbVie

brianajackson / iStockphoto.com

The English High Court has ruled in favour of Fujifilm Kyowa Kirin Biologics  in a case against AbbVie, granting Fujifilm an Arrow declaration allowing it to market a biosimilar of AbbVie’s Humira (adalimumab), a medication used to treat arthritis.


English High Court, Arrow declaration, AbbVie, Fujifilm, patent, Humira, adalimumab, biosimilar

LSIPR